Many healthcare companies grow.
Very few build a legacy that lasts.

Winning in Healthcare: Lessons from Legends reveals the pattern behind the companies that didn't just scale — they became impossible for buyers to ignore.

Eleven real stories. Six frameworks. One system for turning growth into enterprise value.

Get the book →

Winning in Healthcare: Lessons from Legends

In healthcare, you can be right, funded, and growing — and still build something no one wants to buy.

Most companies respond to growth pressure by pushing harder. More pipeline. More product. More presence.

What they miss is the gap that opens underneath all of it.

Revenue grows. Teams expand. Momentum builds. But valuation doesn't keep pace. The distance between what the business is producing and what it's actually worth becomes the most expensive problem in the company — and the hardest one to see from the inside.

It looks like a growth problem, but it usually isn't. It's a structure problem. A narrative problem. A transferability problem.

Winning in Healthcare is about what the gap between growth and enterprise value actually is, where it comes from, and how the companies that became legends closed it.

WHAT'S INSIDE

Eleven stories. One pattern.

This isn't a collection of success highlights. These are the real stories behind some of healthcare's most consequential builders — the ones who started invisible, stayed in the work when it was hard, and came out the other side having built something that lasted.

Across all eleven, a single pattern keeps surfacing. The companies that became truly valuable weren't just growing. They were built as systems — aligned around how value is created, delivered, and recognized by the people who eventually pay for it.

The Doctor Who Built a Unicorn

Iman Abuzeid didn't improve the nursing shortage. She changed the economics behind it. IncredibleHealth is now used by 700+ hospitals, including Johns Hopkins, Cedars-Sinai, and Stanford. What she figured out first changed everything.

The Woman Who Delivered Life

Temie Giwa-Tubosun built a blood logistics network across Africa that has saved tens of thousands of lives. The infrastructure didn't exist. She built it anyway. What that took and what it teaches about building in constrained markets is the point.

The Exit Architect

Twenty-four consecutive quarters of growth in specialty pharmacy don't happen by accident. Mark Montgomery turned BioPlus into a company buyers would compete to acquire — twice. The lesson isn't about the exits. It's about what made them possible.

The Engineer Who Proved Cancer Could Be Detected in Blood

Helmy Eltoukhy built Guardant Health around a clinical insight most people dismissed. The science was real. The challenge was making it believable — to providers, payers, and the market — before competitors could catch up.

The Outsider Who Challenged the System

Ali Parsa left Iran with nothing, built and sold a hospital network in the UK, and then built BabylonHealth — an AI-powered care platform that deployed in some of the most underserved places in the world. His story is about what conviction actually costs.

The Automation Crusader

Sean Lane built Olive into one of the most funded healthcare AI companies of its era. The rise and the reckoning both have something to teach about what happens when momentum outpaces structure.

The Payer Who Crossed the Line

Brian Lobley left the payer side to build something that required thinking like a provider. What he learned about crossing that divide — and about what buyers actually trust —shows up in every conversation Legacy DNA has about enterprise value.

The AI Gambler

Ron Razmi bet on AI in healthcare before it was a market. Zoic Capital's story is about timing, judgment, and the difference between being early and being right.

The Invisible Fix

Malinka Walaliyadde at AKASA built solutions for a problem most health systems didn't realize they could solve. What makes invisible infrastructure valuable — and how to communicate that value — is the chapter CMOs should read twice.

The Orchestrator

Robbie Hughes built Lumeon to coordinate care across complex patient journeys. The care orchestration problem is enormous. The challenge of making that complexity legible to buyers is where his story connects to yours.

The Directory Detective

Meghan Gaffney built Veda around healthcare's data integrity problem — the kind of infrastructure problem nobody wants to own, but everyone depends on. Her story is the best illustration in the book of the Buyer Evaluation Model and why buyers discount companies more than founders expect.

The Enterprise Value Creation System™

Most frameworks describe what to do. This one describes what actually happens. The Enterprise Value Creation System™ (EVCS™) emerged from years of work inside real healthcare companies — watching where value was created, where it was lost, and what the companies that earned premium outcomes had in common.

The Growth vs. Enterprise Value Gap

Growth and enterprise value don't move together automatically. Over time, a gap opens between what a business is producing and what it's actually worth. This framework shows how that gap forms, why it widens silently, and what closes it. It's the conceptual foundation of the entire system, and the most common blind spot for mid-market CEOs preparing for a transaction.

Commercial Clarity

Buyers form a valuation opinion long before diligence begins. This framework maps how commercial clarity — or the lack of it — shapes buyer perception at every stage of a deal. It shows what creates confidence in a company's story and where fragmentation quietly erodes it. Useful for leadership alignment before any external process starts.

The Commercial System Architecture

Most early-stage GTM models stop working at scale. This framework defines what a repeatable, transferable commercial system looks like in healthtech — the structural elements that make growth legible to buyers, not just visible on a dashboard. Built for companies that have grown fast and need to grow cleanly.

Exit Readiness

Exit readiness isn't a checklist you complete in the 90 days before a process. It's a state of the business built over time. This framework defines the five dimensions buyers evaluate when assessing whether a company is acquisition-ready, and where most mid-market companies have gaps they don't see until pressure hits.

The Buyer Evaluation Model

This is how buyers actually evaluate healthcare companies. Before they look at your financials, they're already forming a view of your business based on clarity, consistency, and proof of performance. This framework maps those evaluation signals — what builds buyer confidence and what quietly destroys it — so leadership teams can see the business the way a buyer sees it.

Enterprise Value Drivers

Not all revenue is valued equally. This framework breaks down the specific drivers that determine how a healthcare company is valued at exit, and which ones carry the most weight with strategic acquirers and PE buyers. It gives leadership teams a clear lens for prioritizing growth decisions against their actual impact on enterprise value.
The Enterprise Value Creation System™ and all six frameworks are excerpted from Winning in Healthcare: Lessons from Legends by Dr. Roxie Mooney. But you don't need to have read the book to use them. For bulk licensing or speaking inquiries, contact growth@legacy-dna.com.

The Exit Architect

“Roxie and her team helped us translate vision into velocity. They brought structure, story, and strategy that turned BioPlus into a company buyers could not ignore.”

— Mark Montgomery, Former President, BioPlus Specialty Pharmacy

When BioPlus partnered with Legacy DNA, they were respected but overlooked in a crowded specialty pharmacy market.
13
Consecutive
quarters of growth
$750M
→ $2B
Revenue Growth
+202%
Gross profit increase
2
Premium exits:
Nautic Partners →
Elevance Health
ABOUT THE AUTHOR

Dr. Roxie Mooney, DBA, Founder & CEO, Legacy DNA

Dr. Roxie Mooney has spent more than 20 years inside some of healthcare's most complex and high-growth environments. She has supported more than 100 healthtech launches and been part of four successful exits — including helping scale BioPlus Specialty Pharmacy from approximately $750M to $2B through acquisition into a Fortune 20 health plan.

Her work lives at the intersection of commercialization strategy and enterprise value. She partners with mid-market CEOs, founders, and PE-backed operators at the inflection points where growth must evolve into something that can scale, align, and hold its value under pressure.

That experience — the real work, inside real companies, at the moments that matter — shaped the Enterprise Value Creation System™ and drives every chapter of this book.
Read more about Dr. Roxie →
Ready to read it?

The eleven stories in this book are about healthcare, but the pattern they reveal applies to any company where growth has started to outpace value.

If you're leading a company into its next phase —investment, scale, or exit — these are the stories you should have read before your next board meeting.

Get the book →

Your Next Step

Schedule Your
Strategic Fit Call

It’s a practical conversation to determine whether the Enterprise Value Creation System™ fits your situation and what will most effectively strengthen your valuation.

No pitch. No pressure. Just clarity.

Book my Strategic Fit Call ->